Postinflammatory hyperpigmentation following treatment of hyperkeratosis lenticularis perstans with tazarotene cream 0.1

Cutis. 2019 Aug;104(2):E37-E38.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Dermatologic Agents / administration & dosage
  • Dermatologic Agents / adverse effects*
  • Female
  • Humans
  • Hyperpigmentation / chemically induced*
  • Hyperpigmentation / pathology
  • Keratosis / drug therapy*
  • Middle Aged
  • Nicotinic Acids / administration & dosage
  • Nicotinic Acids / adverse effects*

Substances

  • Dermatologic Agents
  • Nicotinic Acids
  • tazarotene

Supplementary concepts

  • Hyperkeratosis lenticularis perstans